These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 29970185

  • 1. Azithromycin enhances anticancer activity of TRAIL by inhibiting autophagy and up-regulating the protein levels of DR4/5 in colon cancer cells in vitro and in vivo.
    Qiao X, Wang X, Shang Y, Li Y, Chen SZ.
    Cancer Commun (Lond); 2018 Jul 03; 38(1):43. PubMed ID: 29970185
    [Abstract] [Full Text] [Related]

  • 2. Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells.
    Yan S, Qu X, Xu C, Zhu Z, Zhang L, Xu L, Song N, Teng Y, Liu Y.
    J Cancer Res Clin Oncol; 2012 Aug 03; 138(8):1279-89. PubMed ID: 22447040
    [Abstract] [Full Text] [Related]

  • 3. BAY61-3606 potentiates the anti-tumor effects of TRAIL against colon cancer through up-regulating DR4 and down-regulating NF-κB.
    Du J, Wang Y, Chen D, Ji G, Ma Q, Liao S, Zheng Y, Zhang J, Hou Y.
    Cancer Lett; 2016 Dec 28; 383(2):145-153. PubMed ID: 27721019
    [Abstract] [Full Text] [Related]

  • 4. Gefitinib enhances human colon cancer cells to TRAIL-induced apoptosis of via autophagy- and JNK-mediated death receptors upregulation.
    Chen L, Meng Y, Guo X, Sheng X, Tai G, Zhang F, Cheng H, Zhou Y.
    Apoptosis; 2016 Nov 28; 21(11):1291-1301. PubMed ID: 27629794
    [Abstract] [Full Text] [Related]

  • 5. Ginsenoside compound K sensitizes human colon cancer cells to TRAIL-induced apoptosis via autophagy-dependent and -independent DR5 upregulation.
    Chen L, Meng Y, Sun Q, Zhang Z, Guo X, Sheng X, Tai G, Cheng H, Zhou Y.
    Cell Death Dis; 2016 Aug 11; 7(8):e2334. PubMed ID: 27512955
    [Abstract] [Full Text] [Related]

  • 6. Tunicamycin enhances human colon cancer cells to TRAIL-induced apoptosis by JNK-CHOP-mediated DR5 upregulation and the inhibition of the EGFR pathway.
    Guo X, Meng Y, Sheng X, Guan Y, Zhang F, Han Z, Kang Y, Tai G, Zhou Y, Cheng H.
    Anticancer Drugs; 2017 Jan 11; 28(1):66-74. PubMed ID: 27603596
    [Abstract] [Full Text] [Related]

  • 7. Ferroptosis-inducing agents enhance TRAIL-induced apoptosis through upregulation of death receptor 5.
    Lee YS, Lee DH, Jeong SY, Park SH, Oh SC, Park YS, Yu J, Choudry HA, Bartlett DL, Lee YJ.
    J Cell Biochem; 2019 Jan 11; 120(1):928-939. PubMed ID: 30160785
    [Abstract] [Full Text] [Related]

  • 8. Sensitizing TRAIL‑resistant A549 lung cancer cells and enhancing TRAIL‑induced apoptosis with the antidepressant amitriptyline.
    Zinnah KMA, Park SY.
    Oncol Rep; 2021 Jul 11; 46(1):. PubMed ID: 34080659
    [Abstract] [Full Text] [Related]

  • 9. 2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression.
    Stolfi C, Caruso R, Franzè E, Rizzo A, Rotondi A, Monteleone I, Fantini MC, Pallone F, Monteleone G.
    Mol Cancer Ther; 2011 Oct 11; 10(10):1969-81. PubMed ID: 21817114
    [Abstract] [Full Text] [Related]

  • 10. Nutlin-3 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through up-regulation of death receptor 5 (DR5) in human sarcoma HOS cells and human colon cancer HCT116 cells.
    Hori T, Kondo T, Kanamori M, Tabuchi Y, Ogawa R, Zhao QL, Ahmed K, Yasuda T, Seki S, Suzuki K, Kimura T.
    Cancer Lett; 2010 Jan 01; 287(1):98-108. PubMed ID: 19577358
    [Abstract] [Full Text] [Related]

  • 11. Icariin sensitizes human colon cancer cells to TRAIL‑induced apoptosis via ERK‑mediated upregulation of death receptors.
    Kim B, Seo JH, Lee KY, Park B.
    Int J Oncol; 2020 Mar 01; 56(3):821-834. PubMed ID: 32124960
    [Abstract] [Full Text] [Related]

  • 12. Multivalent DR5 peptides activate the TRAIL death pathway and exert tumoricidal activity.
    Pavet V, Beyrath J, Pardin C, Morizot A, Lechner MC, Briand JP, Wendland M, Maison W, Fournel S, Micheau O, Guichard G, Gronemeyer H.
    Cancer Res; 2010 Feb 01; 70(3):1101-10. PubMed ID: 20103630
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of preventive and therapeutic activity of novel non-steroidal anti-inflammatory drug, CG100649, in colon cancer: Increased expression of TNF-related apoptosis-inducing ligand receptors enhance the apoptotic response to combination treatment with TRAIL.
    Woo JK, Kang JH, Jang YS, Ro S, Cho JM, Kim HM, Lee SJ, Oh SH.
    Oncol Rep; 2015 Apr 01; 33(4):1947-55. PubMed ID: 25672292
    [Abstract] [Full Text] [Related]

  • 14. Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL.
    Sung B, Ravindran J, Prasad S, Pandey MK, Aggarwal BB.
    J Biol Chem; 2010 Nov 12; 285(46):35418-27. PubMed ID: 20837473
    [Abstract] [Full Text] [Related]

  • 15. Delivery of tumor-homing TRAIL sensitizer with long-acting TRAIL as a therapy for TRAIL-resistant tumors.
    Oh Y, Swierczewska M, Kim TH, Lim SM, Eom HN, Park JH, Na DH, Kim K, Lee KC, Pomper MG, Lee S.
    J Control Release; 2015 Dec 28; 220(Pt B):671-81. PubMed ID: 26381901
    [Abstract] [Full Text] [Related]

  • 16. Upregulation of Death Receptor 5 and Production of Reactive Oxygen Species Mediate Sensitization of PC-3 Prostate Cancer Cells to TRAIL Induced Apoptosis by Vitisin A.
    Shin D, Kwon HY, Sohn EJ, Nam MS, Kim JH, Lee JC, Ryu SY, Park B, Kim SH.
    Cell Physiol Biochem; 2015 Dec 28; 36(3):1151-62. PubMed ID: 26111475
    [Abstract] [Full Text] [Related]

  • 17. Farnesoid X receptor induces cell death and sensitizes to TRAIL-induced inhibition of growth in colorectal cancer cells through the up-regulation of death receptor 5.
    Hotta M, Sakatani T, Ishino K, Wada R, Kudo M, Yokoyama Y, Yamada T, Yoshida H, Naito Z.
    Biochem Biophys Res Commun; 2019 Nov 19; 519(4):824-831. PubMed ID: 31561852
    [Abstract] [Full Text] [Related]

  • 18. Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer.
    Yang J, Li G, Zhang K.
    Biomed Pharmacother; 2016 Dec 19; 84():1078-1087. PubMed ID: 27780136
    [Abstract] [Full Text] [Related]

  • 19. Accumulation of autophagosomes in breast cancer cells induces TRAIL resistance through downregulation of surface expression of death receptors 4 and 5.
    Di X, Zhang G, Zhang Y, Takeda K, Rivera Rosado LA, Zhang B.
    Oncotarget; 2013 Sep 19; 4(9):1349-64. PubMed ID: 23988408
    [Abstract] [Full Text] [Related]

  • 20. Death receptor 5 is activated by fucosylation in colon cancer cells.
    Zhang B, van Roosmalen IAM, Reis CR, Setroikromo R, Quax WJ.
    FEBS J; 2019 Feb 19; 286(3):555-571. PubMed ID: 30589515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.